Case study: Long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 35, Issue 12, 1996, Pages 1631-1636

  Silver, Archie A ^a,b   Shytle, R Douglas ^a   Philipp, Mary K ^a   Sanberg, Paul R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b TGH University Psychiatry Center   (United States)

Author keywords

nicotine; Tourette's syndrome

Indexed keywords

CLOMIPRAMINE; CLONIDINE; HALOPERIDOL; NEUROLEPTIC AGENT; NICOTINE; PERPHENAZINE; PIMOZIDE;

ADOLESCENT; ARTICLE; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HUMAN; LOCOMOTION; LONG TERM POTENTIATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHOOL CHILD; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029849168     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199612000-00015     Document Type: Article

References (10)

1. Dursan SM, Reveley MA, Bord R, Stirton F (1994), Long lasting improvement of Tourette's syndrome with transdermal nicotine. Lancet 344:157
2. Henningfield JE, Keenan RM (1993), Nicotine delivery kinetics and abuse liability (review). J Consult Clin Psychol 61:743-750
3. Leckman JF, Riddle MA, Hardin MT et al. (1989), The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566-573
4. McConville BJ, Fogelson MH, Norman AB et al. (1991), Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder. Am J Psychiatry 148:793-794
5. Moss DE, Manderscherd PZ, Montgomery SP, Norman AB, Sanberg PR (1989), Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome. Life Sci 44:1421-1525
6. Sanberg PR, McConville BJ, Fogelson HM et al. (1989), Nicotine potentiates the effects of haloperidol in animals and patients with Tourette syndrome. Biomed Pharmacother 43:19-23
7. Shapiro AK, Shapiro ES, Young J, Feinberg TE (1988), Gilles, de la Tourette Syndrome. New York: Raven Press
8. Silver AA, Hagin RA (1990), Gilles de la Tourette's syndrome. In: Disorders of Learning in Childhood. New York: Wiley, pp 469-508
9. Silver AA, Sanberg PR (1993), Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome. Lancet 342:182
10. Silver AA, Shytle RD, Philipp MK, Sanberg PR (1995), Transdermal nicotine in Tourette's syndrome. In: The Effects of Nicotine on Biological Systems, Clarke PBS, Quik M, Thurau K, eds, Advances in Pharmacological Sciences. Boston: Birkhauser Publishers, pp 293-299